It is well recognized that hypogonadism is common in diabetes mellitus (DM) [1][2][3]. However, most of the earlier reports have been in the context of sexual dysfunction particularly resulting in erectile dysfunction (ED) in diabetic men [2]. While ED is an important cause of morbidity in these individuals, there could be other health consequences that also require urgent attention. Testosterone deficiency can affect several facets of the well-being of diabetic patients including sexual performance, mental health, and quality of life [4]. More recently, studies have also focussed on issues that could impact the cardiovascular (CV) and bone health of those affected with DM. Several studies have suggested that hypogonadism particularly in diabetic men is associated with insulin resistance (IR) [5] and a higher occurrence of metabolic syndrome [6]. Clamp studies in patients of DM with testosterone deficiency have revealed a significant reduction in insulin-mediated glucose uptake that has been shown to improve with gonadal hormone replacement in these hypogonadal individuals [7]. These observations suggest that hypogonadism could be associated with significant CV risk among diabetic subjects.It is well known that DM enhances CV risk manifold and that several factors associated with DM such as abdominal obesity, dyslipidemia, and hypertension drive diabetesrelated atherosclerosis and CV risk. However, it is also known that a large part of the CV risk associated with DM remains unexplained by conventional risk factors and the search for newer risk factors is still on. There have been recent reports of hypogonadism in 30-40% of male subjects with DM [1][2][3] particularly in those with evidence of coronary artery disease (CAD) [8]. A significant positive correlation has also been reported between hypogonadism and CAD [8] and atherosclerosis [9]. Coupled with its documented association with insulin resistance and metabolic syndrome, these findings would suggest that testosterone deficiency is not only an important CV risk factor but could also be a major contributor to the CV burden associated with diabetes. The CV risk associated with testosterone deficiency is believed to be related to its known effect on body fat and lean body mass [10] as well as to other independent effects [11] which are not fully understood.Other studies in men without DM have also reported an association of low testosterone levels and increased CV risk [11] and increased carotid intima media thickness (CIMT) [12]. Testosterone is believed to improve coronary blood flow in men and has been shown to induce vasodilatation in isolated rabbit aorta [13].The study by Young et al. [14] from Nigeria on the current issue reinforces the findings of earlier studies from Asia and America and supports a similar contribution of testosterone deficiency to CV burden in countries from the African continent as well. In a cross-sectional study that attempts to determine the prevalence, types, and association of hypogonadism in 108 Nigerian men with established ...